Lataa...
The polycomb group protein BMI1 is a transcriptional target of HDAC inhibitors
Polycomb group (PcG) proteins are overexpressed in several human malignancies including breast cancer. In particular, aberrant expression of BMI1 and eZH2 has been linked to metastasis and poor prognosis in cancer patients. At present, very little is known about the pharmacological inhibitors of PcG...
Tallennettuna:
| Päätekijät: | , , , , |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Landes Bioscience
2010
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3010287/ https://ncbi.nlm.nih.gov/pubmed/20543557 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4161/cc.9.13.12147 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|